1002 related articles for article (PubMed ID: 30867306)
21. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance.
Tu T; Zehnder B; Qu B; Ni Y; Main N; Allweiss L; Dandri M; Shackel N; George J; Urban S
Antiviral Res; 2020 Sep; 181():104865. PubMed ID: 32726641
[TBL] [Abstract][Full Text] [Related]
22. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
23. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
[TBL] [Abstract][Full Text] [Related]
24. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.
Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J
Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717
[TBL] [Abstract][Full Text] [Related]
25. Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.
Köck J; Rösler C; Zhang JJ; Blum HE; Nassal M; Thoma C
PLoS Pathog; 2010 Sep; 6(9):e1001082. PubMed ID: 20824087
[TBL] [Abstract][Full Text] [Related]
26. Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.
Hong X; Hu J
J Virol; 2022 Aug; 96(15):e0071822. PubMed ID: 35867543
[TBL] [Abstract][Full Text] [Related]
27. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.
McDaniel YZ; Patterson SE; Mansky LM
Antiviral Res; 2019 Oct; 170():104540. PubMed ID: 31247245
[TBL] [Abstract][Full Text] [Related]
28. An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity.
Tang L; Remiszewski S; Snedeker A; Chiang LW; Shenk T
Antiviral Res; 2024 Jun; 226():105888. PubMed ID: 38641024
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the molecular events of covalently closed circular DNA synthesis in de novo Hepatitis B virus infection of human hepatoma cells.
Dezhbord M; Lee S; Kim W; Seong BL; Ryu WS
Antiviral Res; 2019 Mar; 163():11-18. PubMed ID: 30639437
[TBL] [Abstract][Full Text] [Related]
30. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
[TBL] [Abstract][Full Text] [Related]
31. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
[TBL] [Abstract][Full Text] [Related]
32. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
Nassal M
Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
[TBL] [Abstract][Full Text] [Related]
33. Mapping the Interactions of HBV cccDNA with Host Factors.
Mohd-Ismail NK; Lim Z; Gunaratne J; Tan YJ
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480501
[TBL] [Abstract][Full Text] [Related]
34. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.
Ogura N; Watashi K; Noguchi T; Wakita T
Biochem Biophys Res Commun; 2014 Sep; 452(3):315-21. PubMed ID: 25150444
[TBL] [Abstract][Full Text] [Related]
35. Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating.
Xi J; Cui X; Liu K; Liu H; Wang J; Hu J
J Virol; 2022 Apr; 96(8):e0039922. PubMed ID: 35389266
[TBL] [Abstract][Full Text] [Related]
36. Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells.
Zhao K; Guo F; Wang J; Zhong Y; Yi J; Teng Y; Xu Z; Zhao L; Li A; Wang Z; Chen X; Cheng X; Xia Y
Hepatology; 2023 Apr; 77(4):1366-1381. PubMed ID: 35718932
[TBL] [Abstract][Full Text] [Related]
37. New Insights on Molecular Mechanism of Hepatitis B Virus Covalently Closed Circular DNA Formation.
Marchetti AL; Guo H
Cells; 2020 Nov; 9(11):. PubMed ID: 33172220
[TBL] [Abstract][Full Text] [Related]
38. DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
Chen Y; Yao Y; Zhao K; Liu C; Yuan Y; Sun H; Huang D; Zheng Y; Zhou Y; Chen J; Wang Y; Wu C; Zhang B; Guan Y; Li F; Pei R; Chen X
J Virol; 2022 Jul; 96(13):e0058522. PubMed ID: 35862693
[TBL] [Abstract][Full Text] [Related]
39. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation.
Wei L; Ploss A
Nat Microbiol; 2020 May; 5(5):715-726. PubMed ID: 32152586
[TBL] [Abstract][Full Text] [Related]
40. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription.
Yu X; Long Q; Shen S; Liu Z; Chandran J; Zhang J; Ding H; Zhang H; Cai D; Kim ES; Huang Y; Guo H
Antiviral Res; 2023 Mar; 211():105552. PubMed ID: 36737008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]